Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aytu BioPharma Q1 EPS $(1.48) Down From $(1.20) YoY, Sales $22.10M Miss $27.73M Estimate

Author: Benzinga Newsdesk | November 14, 2023 05:30pm
Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(1.48) per share. This is a 23.33 percent decrease over losses of $(1.20) per share from the same period last year. The company reported quarterly sales of $22.10 million which missed the analyst consensus estimate of $27.73 million by 20.31 percent. This is a 20.09 percent decrease over sales of $27.66 million the same period last year.

Posted In: AYTU


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist